Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

Company Overview - Outset Medical, Inc. is a medical technology company focused on pioneering technology to reduce the cost and complexity of dialysis [4] - The Tablo® Hemodialysis System is FDA cleared for use from the hospital to the home, representing a significant technological advancement in dialysis [4] - Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by anyone [4] Financial Results Announcement - Outset Medical will release financial results for the fourth quarter and full-year 2024 after the close of trading on February 19, 2025 [1] - A conference call will be hosted by Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on the same day to discuss financial and operating results [2][3] Conference Call Details - Participants interested in joining the conference call must register online to receive dial-in numbers and a unique pin [3] - It is encouraged for participants to register more than 15 minutes before the start of the call [3] - A live and archived webcast of the event will be available on the "Investors" section of the Outset website [3]